Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$37.32 - $49.29 $106,324 - $140,427
-2,849 Reduced 12.8%
19,409 $732,000
Q2 2023

Aug 04, 2023

BUY
$39.98 - $47.68 $30,344 - $36,189
759 Added 3.53%
22,258 $1.01 Million
Q1 2023

May 09, 2023

BUY
$37.58 - $52.57 $220,519 - $308,480
5,868 Added 37.54%
21,499 $871,000
Q4 2022

Feb 13, 2023

BUY
$49.7 - $57.71 $63,864 - $74,157
1,285 Added 8.96%
15,631 $796,000
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $54,614 - $67,735
1,014 Added 7.61%
14,346 $774,000
Q2 2022

Aug 08, 2022

SELL
$63.83 - $80.0 $422,299 - $529,280
-6,616 Reduced 33.17%
13,332 $857,000
Q1 2022

May 12, 2022

SELL
$76.85 - $89.45 $411,454 - $478,915
-5,354 Reduced 21.16%
19,948 $1.52 Million
Q4 2021

Feb 15, 2022

SELL
$74.57 - $87.19 $1.49 Million - $1.74 Million
-19,959 Reduced 44.1%
25,302 $2.19 Million
Q3 2021

Nov 12, 2021

BUY
$73.77 - $83.61 $2,729 - $3,093
37 Added 0.08%
45,261 $3.64 Million
Q2 2021

Aug 06, 2021

BUY
$80.5 - $88.01 $288,753 - $315,691
3,587 Added 8.61%
45,224 $3.64 Million
Q1 2021

May 13, 2021

SELL
$76.38 - $86.03 $221,120 - $249,056
-2,895 Reduced 6.5%
41,637 $3.51 Million
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $219,083 - $239,338
2,906 Added 6.98%
44,532 $3.57 Million
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $1.68 Million - $1.95 Million
-21,475 Reduced 34.03%
41,626 $3.35 Million
Q2 2020

Aug 12, 2020

SELL
$78.66 - $94.14 $1.25 Million - $1.5 Million
-15,939 Reduced 20.17%
63,101 $5.43 Million
Q1 2020

May 13, 2020

BUY
$71.57 - $93.3 $472,218 - $615,593
6,598 Added 9.11%
79,040 $6.42 Million
Q4 2019

Feb 13, 2020

BUY
$76.7 - $88.45 $5.56 Million - $6.41 Million
72,442 New
72,442 $6.06 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.